Clinical Significance of Time‐to‐Surgery and <scp>COVID</scp>‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer
Time-to-surgery is an independent predictor of long-term survival in surgically treated NSCLC. In general, the COVID-19 pandemic caused a significant delay in the elapsed time until surgery, but the specific COVID-19 waves had no significant impact on time-to-surgery.
Authors
- Kristóf Csende
- Áron Ghimessy (ORCID: https://orcid.org/0000-0002-0385-1586)
- Bence Ferencz (ORCID: https://orcid.org/0000-0001-9820-2441)
- Áron Gellért
- Levente Bogyó
- F Rényi-Vámos
- László Mészáros (ORCID: https://orcid.org/0000-0001-5447-6440)
- Balázs Gieszer
- Balázs Döme (ORCID: https://orcid.org/0000-0001-8799-8624)
- János Fillinger (ORCID: https://orcid.org/0000-0003-1877-8702)
- Ákos Kocsis
- Klára Török
- Péter Radeczky (ORCID: https://orcid.org/0000-0001-5756-2328)
- László Agócs
- Gábor Tarsoly
- Hanna Tihanyi (ORCID: https://orcid.org/0009-0003-4409-9217)
- Sára Lality
- Zsolt Megyesfalvi
- Márton Csaba
Institutions
- Semmelweis University (HU)
- Lund University (SE)
- Comprehensive Cancer Center Vienna (AT)
- National Institute of Oncology (HU)
- Országos Korányi Tbc és Pulmonológiai Intézet (HU)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/1759-7714.70163
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Semmelweis Egyetem
- Austrian Science Fund
- Magyar Tudományos Akadémia
- Innovációs és Technológiai Minisztérium
- National Research, Development and Innovation Office